{"DataElement":{"publicId":"2647962","version":"1","preferredName":"Fluorescence in situ Hybridization Diagnostic Procedure Chromosome 17 Signal Polysomy Result Percentage Value","preferredDefinition":"the percentage value related to polysomy result of chromosome 17 (one of the three pairs in the fifth group (or group E) of human chromosomes according to the current classification for humans) signals to yield a diagnostic result  through a physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin.","longName":"FISH_DP_CH17_S_R_CPV","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2647965","version":"1","preferredName":"Fluorescence in situ Hybridization Diagnostic Procedure Chromosome 17 Signal Polysomy Result","preferredDefinition":"information related to polysomy result of chromosome 17 (one of the three pairs in the fifth group (or group E) of human chromosomes according to the current classification for humans) signals to yield a diagnostic result  through a physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin.","longName":"FISH_DP_CHR17_S_P_RS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2647294","version":"1","preferredName":"Fluorescence in situ Hybridization Diagnostic Procedure","preferredDefinition":"A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.:Methods, procedures, and tests performed to diagnose disease, disordered function, or disability.","longName":"C17563:C18020","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnostic Procedure","conceptCode":"C18020","definition":"Any procedure or test to diagnose a disease or disorder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"323EF388-1561-0891-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-06","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-06","modifiedBy":"ONEDATA","dateModified":"2007-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2647963","version":"1","preferredName":"Chromosome 17 Signal Polysomy Result","preferredDefinition":"One of the three pairs in the fifth group (or group E) of human chromosomes according to the current classification for humans.:A detectable physical quantity or impulse (e.g., voltage, current, or magnetic field strength). (from Merriam Webster OnLine):No Value Exists:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C13212:C43382:C36331:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Chromosome 17","conceptCode":"C13212","definition":"The designation for each member of the seventeenth largest human autosomal chromosome pair. Chromosome 17 spans more than 81 million base pairs and represents between 2.5 and 3% of the total DNA in normal diploid cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Signal","conceptCode":"C43382","definition":"A detectable physical quantity or impulse (e.g., voltage, current, or magnetic field strength).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Polysomy","conceptCode":"C36331","definition":"The condition of having additional copies of a chromosome present in a cell.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"324B0467-2611-0AE2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-07","modifiedBy":"ONEDATA","dateModified":"2007-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"324B0467-2622-0AE2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-06","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-07","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2181247","version":"1","preferredName":"Cell Percentage Value","preferredDefinition":"information related to the percentage value for a cell count.","longName":"CELL_PTG_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":"0","format":"%","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D3B7ECCE-4611-6532-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-02-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-19","modifiedBy":"KNABLEJ","dateModified":"2022-03-15","changeDescription":"3/15/22 jk added \"Qualified\" RS as part of MCL quarterly content review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811952","version":"1","longName":"Cytogenetics","context":"CTEP"},{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Percentage greater than or eq","type":"Preferred Question Text","description":"Percentage greater than or equal to 3 Chromosome 17 signals","url":null,"context":"CTEP"}],"origin":"NCCTG CRF:North Central Cancer Treatment Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"324B0467-25F9-0AE2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-06","endDate":null,"createdBy":"ALAIS","dateCreated":"2007-06-07","modifiedBy":"ALAIS","dateModified":"2009-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}